Gina López-Cantillo, Claudia Urueña, Bernardo Armando Camacho, Cesar Ramírez-Segura. Front Immunol 2022
Times Cited: 5
Times Cited: 5
Times Cited
Times Co-cited
Similarity
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.
Sabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, Doncho Zhelev, Robbie G Majzner, Molly T Radosevich, Shaurya Dhingra, Elena Sotillo, Samantha Buongervino, Guillem Pascual-Pasto,[...]. Cancer Cell 2022
Sabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, Doncho Zhelev, Robbie G Majzner, Molly T Radosevich, Shaurya Dhingra, Elena Sotillo, Samantha Buongervino, Guillem Pascual-Pasto,[...]. Cancer Cell 2022
40
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
40
CAR-NK cells for cancer immunotherapy: from bench to bedside.
Leisheng Zhang, Yuan Meng, Xiaoming Feng, Zhongchao Han. Biomark Res 2022
Leisheng Zhang, Yuan Meng, Xiaoming Feng, Zhongchao Han. Biomark Res 2022
40
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR.
Dana Stenger, Tanja A Stief, Theresa Kaeuferle, Semjon Willier, Felicitas Rataj, Kilian Schober, Binje Vick, Ramin Lotfi, Beate Wagner, Thomas G P Grünewald,[...]. Blood 2020
Dana Stenger, Tanja A Stief, Theresa Kaeuferle, Semjon Willier, Felicitas Rataj, Kilian Schober, Binje Vick, Ramin Lotfi, Beate Wagner, Thomas G P Grünewald,[...]. Blood 2020
40
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.
Christopher Ronald Funk, Shuhua Wang, Kevin Z Chen, Alexandra Waller, Aditi Sharma, Claudia L Edgar, Vikas A Gupta, Shanmuganathan Chandrakasan, Jaquelyn T Zoine, Andrew Fedanov,[...]. Blood 2022
Christopher Ronald Funk, Shuhua Wang, Kevin Z Chen, Alexandra Waller, Aditi Sharma, Claudia L Edgar, Vikas A Gupta, Shanmuganathan Chandrakasan, Jaquelyn T Zoine, Andrew Fedanov,[...]. Blood 2022
40
Advances in Universal CAR-T Cell Therapy.
Haolong Lin, Jiali Cheng, Wei Mu, Jianfeng Zhou, Li Zhu. Front Immunol 2021
Haolong Lin, Jiali Cheng, Wei Mu, Jianfeng Zhou, Li Zhu. Front Immunol 2021
40
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.
Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi N Berneman, Eva Lion, Feifei Luo,[...]. J Hematol Oncol 2020
Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi N Berneman, Eva Lion, Feifei Luo,[...]. J Hematol Oncol 2020
40
'Off-the-shelf' allogeneic CAR T cells: development and challenges.
S Depil, P Duchateau, S A Grupp, G Mufti, L Poirot. Nat Rev Drug Discov 2020
S Depil, P Duchateau, S A Grupp, G Mufti, L Poirot. Nat Rev Drug Discov 2020
40
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
Justin Eyquem, Jorge Mansilla-Soto, Theodoros Giavridis, Sjoukje J C van der Stegen, Mohamad Hamieh, Kristen M Cunanan, Ashlesha Odak, Mithat Gönen, Michel Sadelain. Nature 2017
Justin Eyquem, Jorge Mansilla-Soto, Theodoros Giavridis, Sjoukje J C van der Stegen, Mohamad Hamieh, Kristen M Cunanan, Ashlesha Odak, Mithat Gönen, Michel Sadelain. Nature 2017
40
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.
D Sommermeyer, M Hudecek, P L Kosasih, T Gogishvili, D G Maloney, C J Turtle, S R Riddell. Leukemia 2016
D Sommermeyer, M Hudecek, P L Kosasih, T Gogishvili, D G Maloney, C J Turtle, S R Riddell. Leukemia 2016
40
Universal CARs, universal T cells, and universal CAR T cells.
Juanjuan Zhao, Quande Lin, Yongping Song, Delong Liu. J Hematol Oncol 2018
Juanjuan Zhao, Quande Lin, Yongping Song, Delong Liu. J Hematol Oncol 2018
40
Natural killer cells in antitumour adoptive cell immunotherapy.
Tamara J Laskowski, Alexander Biederstädt, Katayoun Rezvani. Nat Rev Cancer 2022
Tamara J Laskowski, Alexander Biederstädt, Katayoun Rezvani. Nat Rev Cancer 2022
20
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
J G Villablanca, A A Khan, V I Avramis, R C Seeger, K K Matthay, N K Ramsay, C P Reynolds. J Clin Oncol 1995
J G Villablanca, A A Khan, V I Avramis, R C Seeger, K K Matthay, N K Ramsay, C P Reynolds. J Clin Oncol 1995
20
Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions.
Jessica Matta, Myriam Baratin, Laurent Chiche, Jean-Marie Forel, Céline Cognet, Guillemette Thomas, Catherine Farnarier, Christelle Piperoglou, Laurent Papazian, Damien Chaussabel,[...]. Blood 2013
Jessica Matta, Myriam Baratin, Laurent Chiche, Jean-Marie Forel, Céline Cognet, Guillemette Thomas, Catherine Farnarier, Christelle Piperoglou, Laurent Papazian, Damien Chaussabel,[...]. Blood 2013
20
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule.
A Gregorio, M V Corrias, R Castriconi, A Dondero, M Mosconi, C Gambini, A Moretta, L Moretta, C Bottino. Histopathology 2008
A Gregorio, M V Corrias, R Castriconi, A Dondero, M Mosconi, C Gambini, A Moretta, L Moretta, C Bottino. Histopathology 2008
20
Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages.
Francesca Bellora, Alessandra Dondero, Maria Valeria Corrias, Beatrice Casu, Stefano Regis, Fabio Caliendo, Alessandro Moretta, Mario Cazzola, Chiara Elena, Luciana Vinti,[...]. J Immunol 2017
Francesca Bellora, Alessandra Dondero, Maria Valeria Corrias, Beatrice Casu, Stefano Regis, Fabio Caliendo, Alessandro Moretta, Mario Cazzola, Chiara Elena, Luciana Vinti,[...]. J Immunol 2017
20
KIR and KIR ligand polymorphism: a new area for clinical applications?
M Falco, L Moretta, A Moretta, C Bottino. Tissue Antigens 2013
M Falco, L Moretta, A Moretta, C Bottino. Tissue Antigens 2013
20
PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO.
Nikolai Siebert, Maxi Zumpe, Madlen Jüttner, Sascha Troschke-Meurer, Holger N Lode. Oncoimmunology 2017
Nikolai Siebert, Maxi Zumpe, Madlen Jüttner, Sascha Troschke-Meurer, Holger N Lode. Oncoimmunology 2017
20
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism.
Jerod L Ptacin, Carolina E Caffaro, Lina Ma, Kristine M San Jose Gall, Hans R Aerni, Nicole V Acuff, Rob W Herman, Yelena Pavlova, Michael J Pena, David B Chen,[...]. Nat Commun 2021
Jerod L Ptacin, Carolina E Caffaro, Lina Ma, Kristine M San Jose Gall, Hans R Aerni, Nicole V Acuff, Rob W Herman, Yelena Pavlova, Michael J Pena, David B Chen,[...]. Nat Commun 2021
20
Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC.
Christina Battke, Romana Ruiss, Ulrich Welsch, Pauline Wimberger, Stephan Lang, Simon Jochum, Reinhard Zeidler. Cancer Immunol Immunother 2011
Christina Battke, Romana Ruiss, Ulrich Welsch, Pauline Wimberger, Stephan Lang, Simon Jochum, Reinhard Zeidler. Cancer Immunol Immunother 2011
20
Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma.
Young Bae Choi, Meong Hi Son, Hee Won Cho, Youngeun Ma, Ji Won Lee, Eun-Suk Kang, Keon Hee Yoo, Jung Hyun Her, Okjae Lim, Miyoung Jung,[...]. PLoS One 2019
Young Bae Choi, Meong Hi Son, Hee Won Cho, Youngeun Ma, Ji Won Lee, Eun-Suk Kang, Keon Hee Yoo, Jung Hyun Her, Okjae Lim, Miyoung Jung,[...]. PLoS One 2019
20
Searching for alternative hematopoietic stem cell donors for pediatric patients.
V Rocha, F Locatelli. Bone Marrow Transplant 2008
V Rocha, F Locatelli. Bone Marrow Transplant 2008
20
Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155.
Baofu Zhang, Weina Zhao, Huizhong Li, Yuanyuan Chen, Hui Tian, Liantao Li, Longzhen Zhang, Chao Gao, Junnian Zheng. Cancer Immunol Immunother 2016
Baofu Zhang, Weina Zhao, Huizhong Li, Yuanyuan Chen, Hui Tian, Liantao Li, Longzhen Zhang, Chao Gao, Junnian Zheng. Cancer Immunol Immunother 2016
20
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.
Nicholas D Huntington, Nicolas Legrand, Nuno L Alves, Barbara Jaron, Kees Weijer, Ariane Plet, Erwan Corcuff, Erwan Mortier, Yannick Jacques, Hergen Spits,[...]. J Exp Med 2009
Nicholas D Huntington, Nicolas Legrand, Nuno L Alves, Barbara Jaron, Kees Weijer, Ariane Plet, Erwan Corcuff, Erwan Mortier, Yannick Jacques, Hergen Spits,[...]. J Exp Med 2009
20
Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma.
Toni Illhardt, Jacek Toporski, Tobias Feuchtinger, Dominik Turkiewicz, Heiko-Manuel Teltschik, Martin Ebinger, Carl-Philipp Schwarze, Ursula Holzer, Holger N Lode, Michael H Albert,[...]. Biol Blood Marrow Transplant 2018
Toni Illhardt, Jacek Toporski, Tobias Feuchtinger, Dominik Turkiewicz, Heiko-Manuel Teltschik, Martin Ebinger, Carl-Philipp Schwarze, Ursula Holzer, Holger N Lode, Michael H Albert,[...]. Biol Blood Marrow Transplant 2018
20
High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes.
Steven G DuBois, Margaret E Macy, Tara O Henderson. Am Soc Clin Oncol Educ Book 2022
Steven G DuBois, Margaret E Macy, Tara O Henderson. Am Soc Clin Oncol Educ Book 2022
25
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma.
Ombretta Melaiu, Marco Chierici, Valeria Lucarini, Giuseppe Jurman, Libenzio Adrian Conti, Rita De Vito, Renata Boldrini, Loredana Cifaldi, Aurora Castellano, Cesare Furlanello,[...]. Nat Commun 2020
Ombretta Melaiu, Marco Chierici, Valeria Lucarini, Giuseppe Jurman, Libenzio Adrian Conti, Rita De Vito, Renata Boldrini, Loredana Cifaldi, Aurora Castellano, Cesare Furlanello,[...]. Nat Commun 2020
20
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.
Roberta Castriconi, Alessandra Dondero, Raffaella Augugliaro, Claudia Cantoni, Barbara Carnemolla, Angela Rita Sementa, Francesca Negri, Romana Conte, Maria Valeria Corrias, Lorenzo Moretta,[...]. Proc Natl Acad Sci U S A 2004
Roberta Castriconi, Alessandra Dondero, Raffaella Augugliaro, Claudia Cantoni, Barbara Carnemolla, Angela Rita Sementa, Francesca Negri, Romana Conte, Maria Valeria Corrias, Lorenzo Moretta,[...]. Proc Natl Acad Sci U S A 2004
20
Donor NK Cells and IL-15 promoted engraftment in nonmyeloablative allogeneic bone marrow transplantation.
Bo Hu, Guangming Bao, Yinsheng Zhang, Dandan Lin, Yan Wu, Depei Wu, Haiyan Liu. J Immunol 2012
Bo Hu, Guangming Bao, Yinsheng Zhang, Dandan Lin, Yan Wu, Depei Wu, Haiyan Liu. J Immunol 2012
20
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies.
Kristina Ihrmark Lundberg, Diana Treis, John Inge Johnsen. Curr Oncol Rep 2022
Kristina Ihrmark Lundberg, Diana Treis, John Inge Johnsen. Curr Oncol Rep 2022
20
Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Alice Bertaina, Maria Grazia Roncarolo. Front Immunol 2019
Alice Bertaina, Maria Grazia Roncarolo. Front Immunol 2019
20
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors.
Robbie G Majzner, Johanna L Theruvath, Anandani Nellan, Sabine Heitzeneder, Yongzhi Cui, Christopher W Mount, Skyler P Rietberg, Miles H Linde, Peng Xu, Christopher Rota,[...]. Clin Cancer Res 2019
Robbie G Majzner, Johanna L Theruvath, Anandani Nellan, Sabine Heitzeneder, Yongzhi Cui, Christopher W Mount, Skyler P Rietberg, Miles H Linde, Peng Xu, Christopher Rota,[...]. Clin Cancer Res 2019
20
Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.
Patrick Ming-Kuen Tang, Shuang Zhou, Xiao-Ming Meng, Qing-Ming Wang, Chun-Jie Li, Guang-Yu Lian, Xiao-Ru Huang, Yong-Jiang Tang, Xin-Yuan Guan, Bryan Ping-Yen Yan,[...]. Nat Commun 2017
Patrick Ming-Kuen Tang, Shuang Zhou, Xiao-Ming Meng, Qing-Ming Wang, Chun-Jie Li, Guang-Yu Lian, Xiao-Ru Huang, Yong-Jiang Tang, Xin-Yuan Guan, Bryan Ping-Yen Yan,[...]. Nat Commun 2017
20
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice.
Yaya Chu, Gaurav Nayyar, Susiyan Jiang, Jeremy M Rosenblum, Patrick Soon-Shiong, Jeffrey T Safrit, Dean A Lee, Mitchell S Cairo. J Immunother Cancer 2021
Yaya Chu, Gaurav Nayyar, Susiyan Jiang, Jeremy M Rosenblum, Patrick Soon-Shiong, Jeffrey T Safrit, Dean A Lee, Mitchell S Cairo. J Immunother Cancer 2021
20
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
Matteo Caforio, Cristina Sorino, Ignazio Caruana, Gerrit Weber, Antonio Camera, Loredana Cifaldi, Biagio De Angelis, Francesca Del Bufalo, Alessia Vitale, Bianca Maria Goffredo,[...]. J Immunother Cancer 2021
Matteo Caforio, Cristina Sorino, Ignazio Caruana, Gerrit Weber, Antonio Camera, Loredana Cifaldi, Biagio De Angelis, Francesca Del Bufalo, Alessia Vitale, Bianca Maria Goffredo,[...]. J Immunother Cancer 2021
20
Oral cancer cell‑derived exosomes modulate natural killer cell activity by regulating the receptors on these cells.
Xueqin Zhu, Xing Qin, Xiaoning Wang, Yingnan Wang, Wei Cao, Jianjun Zhang, Wantao Chen. Int J Mol Med 2020
Xueqin Zhu, Xing Qin, Xiaoning Wang, Yingnan Wang, Wei Cao, Jianjun Zhang, Wantao Chen. Int J Mol Med 2020
20
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
Daniela Pende, Stefania Marcenaro, Michela Falco, Stefania Martini, Maria Ester Bernardo, Daniela Montagna, Elisa Romeo, Céline Cognet, Miryam Martinetti, Rita Maccario,[...]. Blood 2009
Daniela Pende, Stefania Marcenaro, Michela Falco, Stefania Martini, Maria Ester Bernardo, Daniela Montagna, Elisa Romeo, Céline Cognet, Miryam Martinetti, Rita Maccario,[...]. Blood 2009
20
Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more.
Laura Chiossone, Margaux Vienne, Yann M Kerdiles, Eric Vivier. Semin Immunol 2017
Laura Chiossone, Margaux Vienne, Yann M Kerdiles, Eric Vivier. Semin Immunol 2017
20
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Loredana Ruggeri, Marusca Capanni, Elena Urbani, Katia Perruccio, Warren D Shlomchik, Antonella Tosti, Sabrina Posati, Daniela Rogaia, Francesco Frassoni, Franco Aversa,[...]. Science 2002
Loredana Ruggeri, Marusca Capanni, Elena Urbani, Katia Perruccio, Warren D Shlomchik, Antonella Tosti, Sabrina Posati, Daniela Rogaia, Francesco Frassoni, Franco Aversa,[...]. Science 2002
20
Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients.
Dominique Valteau-Couanet, Christophe Leboulaire, Kim Maincent, Muriel Tournier, Olivier Hartmann, Jean Bénard, Françoise Beaujean, Catherine Boccaccio, Laurence Zitvogel, Eric Angevin. Blood 2002
Dominique Valteau-Couanet, Christophe Leboulaire, Kim Maincent, Muriel Tournier, Olivier Hartmann, Jean Bénard, Françoise Beaujean, Catherine Boccaccio, Laurence Zitvogel, Eric Angevin. Blood 2002
20
Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes.
Ignazio Caruana, Barbara Savoldo, Valentina Hoyos, Gerrit Weber, Hao Liu, Eugene S Kim, Michael M Ittmann, Dario Marchetti, Gianpietro Dotti. Nat Med 2015
Ignazio Caruana, Barbara Savoldo, Valentina Hoyos, Gerrit Weber, Hao Liu, Eugene S Kim, Michael M Ittmann, Dario Marchetti, Gianpietro Dotti. Nat Med 2015
20
Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals.
Jaewon Lee, Tianxiang Zhang, Ilwoong Hwang, Ahrom Kim, Larissa Nitschke, MinJae Kim, Jeannine M Scott, Yosuke Kamimura, Lewis L Lanier, Sungjin Kim. Immunity 2015
Jaewon Lee, Tianxiang Zhang, Ilwoong Hwang, Ahrom Kim, Larissa Nitschke, MinJae Kim, Jeannine M Scott, Yosuke Kamimura, Lewis L Lanier, Sungjin Kim. Immunity 2015
20
Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use.
Matthew D Blunt, Salim I Khakoo. Int J Immunogenet 2020
Matthew D Blunt, Salim I Khakoo. Int J Immunogenet 2020
20
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Isaac Yaniv, Genevieve Laureys, Penelope Brock, Jean Marie Michon, Cormac Owens,[...]. Lancet Oncol 2018
Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Isaac Yaniv, Genevieve Laureys, Penelope Brock, Jean Marie Michon, Cormac Owens,[...]. Lancet Oncol 2018
20
The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives.
Laurence Blavier, Ren-Ming Yang, Yves A DeClerck. Cancers (Basel) 2020
Laurence Blavier, Ren-Ming Yang, Yves A DeClerck. Cancers (Basel) 2020
20
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.
Brian H Kushner, Irina Ostrovnaya, Irene Y Cheung, Deborah Kuk, Shakeel Modak, Kim Kramer, Stephen S Roberts, Ellen M Basu, Karima Yataghene, Nai-Kong V Cheung. Oncotarget 2016
Brian H Kushner, Irina Ostrovnaya, Irene Y Cheung, Deborah Kuk, Shakeel Modak, Kim Kramer, Stephen S Roberts, Ellen M Basu, Karima Yataghene, Nai-Kong V Cheung. Oncotarget 2016
20
Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia.
Chang-Sook Hong, Priyanka Sharma, Saigopalakrishna S Yerneni, Patricia Simms, Edwin K Jackson, Theresa L Whiteside, Michael Boyiadzis. Sci Rep 2017
Chang-Sook Hong, Priyanka Sharma, Saigopalakrishna S Yerneni, Patricia Simms, Edwin K Jackson, Theresa L Whiteside, Michael Boyiadzis. Sci Rep 2017
20
Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
Onder Alpdogan, Jeffrey M Eng, Stephanie J Muriglan, Lucy M Willis, Vanessa M Hubbard, Kartono H Tjoe, Theis H Terwey, Adam Kochman, Marcel R M van den Brink. Blood 2005
Onder Alpdogan, Jeffrey M Eng, Stephanie J Muriglan, Lucy M Willis, Vanessa M Hubbard, Kartono H Tjoe, Theis H Terwey, Adam Kochman, Marcel R M van den Brink. Blood 2005
20
Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors.
Aicha E Quamine, Mallery R Olsen, Monica M Cho, Christian M Capitini. Cancers (Basel) 2021
Aicha E Quamine, Mallery R Olsen, Monica M Cho, Christian M Capitini. Cancers (Basel) 2021
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.